Neurocrine Biosciences Inc (NBIX)
117.44
-5.44
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
117.22
-0.22
(-0.19%)
After-Hours: 20:00
Neurocrine Biosciences Net Income (TTM): 385.90M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 385.90M |
| June 30, 2024 | 339.20M |
| March 31, 2024 | 369.70M |
| December 31, 2023 | 249.70M |
| September 30, 2023 | 191.00M |
| June 30, 2023 | 176.40M |
| March 31, 2023 | 64.00M |
| December 31, 2022 | 154.50M |
| September 30, 2022 | 58.20M |
| June 30, 2022 | 12.20M |
| March 31, 2022 | 71.40M |
| December 31, 2021 | 89.60M |
| September 30, 2021 | 444.80M |
| June 30, 2021 | 364.70M |
| March 31, 2021 | 402.00M |
| December 31, 2020 | 407.30M |
| September 30, 2020 | 93.40M |
| June 30, 2020 | 204.80M |
| March 31, 2020 | 176.50M |
| December 31, 2019 | 37.00M |
| September 30, 2019 | 21.07M |
| June 30, 2019 | 18.03M |
| March 31, 2019 | -39.18M |
| December 31, 2018 | 21.10M |
| September 30, 2018 | 9.927M |
| Date | Value |
|---|---|
| June 30, 2018 | -51.96M |
| March 31, 2018 | -106.03M |
| December 31, 2017 | -142.54M |
| September 30, 2017 | -194.10M |
| June 30, 2017 | -219.86M |
| March 31, 2017 | -200.15M |
| December 31, 2016 | -141.09M |
| September 30, 2016 | -125.75M |
| June 30, 2016 | -123.29M |
| March 31, 2016 | -107.00M |
| December 31, 2015 | -88.93M |
| September 30, 2015 | -79.06M |
| June 30, 2015 | -60.50M |
| March 31, 2015 | -49.89M |
| December 31, 2014 | -60.54M |
| September 30, 2014 | -51.74M |
| June 30, 2014 | -47.00M |
| March 31, 2014 | -45.86M |
| December 31, 2013 | -46.09M |
| September 30, 2013 | -25.96M |
| June 30, 2013 | -17.90M |
| March 31, 2013 | -6.164M |
| December 31, 2012 | 5.025M |
| September 30, 2012 | -3.134M |
| June 30, 2012 | 31.33M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
12.20M
Minimum
Jun 2022
444.80M
Maximum
Sep 2021
214.62M
Average
183.75M
Median
Net Income (TTM) Benchmarks
| Repligen Corp | -20.73M |
| West Pharmaceutical Services Inc | 499.60M |
| Bruker Corp | 304.90M |
| The Cooper Companies Inc | 359.30M |
| Integra Lifesciences Holdings Corp | -6.544M |